Benzinga··Vandana SinghWest Pharmaceutical Lifts 2026 Outlook on GLP-1 Boom, Authorizes $1B Buyback
West Pharmaceutical beats Q1 earnings with 21% sales growth driven by GLP-1 demand, raises full-year guidance, and launches $1B share repurchase program.
WSTearnings beatorganic growth